Browse > Article
http://dx.doi.org/10.1016/j.jgr.2016.07.003

Induction of Nrf2/ARE-mediated cytoprotective genes by red ginseng oil through ASK1-MKK4/7-JNK and p38 MAPK signaling pathways in HepG2 cells  

Bak, Min Ji (Department of Food and Life Sciences, College of Biomedical Science and Engineering, Inje University)
Truong, Van-Long (Department of Food and Life Sciences, College of Biomedical Science and Engineering, Inje University)
Ko, Se-Yeon (Department of Food and Life Sciences, College of Biomedical Science and Engineering, Inje University)
Nguyen, Xuan Ngan Giang (Department of Food and Life Sciences, College of Biomedical Science and Engineering, Inje University)
Jun, Mira (Department of Food Science and Nutrition, Dong-A University)
Hong, Soon-Gi (Ginseng Product Research Institute, R&D Headquarters, Korea Ginseng Corporation)
Lee, Jong-Won (Ginseng Product Research Institute, R&D Headquarters, Korea Ginseng Corporation)
Jeong, Woo-Sik (Department of Food and Life Sciences, College of Biomedical Science and Engineering, Inje University)
Publication Information
Journal of Ginseng Research / v.40, no.4, 2016 , pp. 423-430 More about this Journal
Abstract
Background: The induction of cellular defensive genes such as phase II detoxifying and antioxidant enzymes is a highly effective strategy for protection against carcinogenesis as well as slowing cancer development. Transcription factor Nrf2 (nuclear factor E2-related factor 2) is responsible for activation of phase II enzymes induced by natural chemopreventive compounds. Methods: Red ginseng oil (RGO) was extracted using a supercritical $CO_2$ extraction system and chemical profile of RGO was investigated by GC/MS. Effects of RGO on regulation of the Nrf2/antioxidant response element (ARE) pathway were determined by ARE-luciferase assay, western blotting, and confocal microscopy. Results: The predominant components of RGO were 9,12-octadecadienoic acid (31.48%), bicyclo[10.1.0] tridec-1-ene (22.54%), and 22,23-dihydrostigmasterol (16.90%). RGO treatment significantly increased nuclear translocation of Nrf2 as well as ARE reporter gene activity, leading to upregulation of heme oxygenase-1 and NAD(P)H:quinone oxidoreductase 1. Phosphorylation of the upstream kinases such as apoptosis signal-regulating kinase (ASK)1, mitogen-activated protein kinase (MAPK) kinase (MKK)4/7, c-Jun N-terminal kinase (JNK), and p38 MAPK were enhanced by treatment with RGO. In addition, RGO-mediated Nrf2 expression and nuclear translocation was attenuated by JNK inhibitor SP600125 and p38 MAPK inhibitor SB202190. Conclusion: RGO could be used as a potential chemopreventive agent, possibly by induction of Nrf2/ARE-mediated phase II enzymes via ASK1-MKK4/7-JNK and p38 MAPK signaling pathways.
Keywords
antioxidant response element; cytoprotection; nuclear factor E2-related factor 2; phase II enzyme; red ginseng oil;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 2008;269:291-304.   DOI
2 Marshall CJ. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 1994;4:82-9.   DOI
3 Cuevas BD, Abell AN, Johnson GL. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007;26:3159-71.   DOI
4 Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009;284:13291-5.   DOI
5 Zhao CR, Gao ZH, Qu XJ. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiol 2010;34:523-33.   DOI
6 Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005;224:171-84.   DOI
7 Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011;16:123-40.   DOI
8 Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong ANT. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett 2006;243:170-92.   DOI
9 Cui Y, Wang Q, Yi X, Zhang X. Effects of fatty acids on CYP2A5 and Nrf2 expression in mouse primary hepatocytes. Biochem Genet 2016;54:29-40.   DOI
10 Wang X, Destrument A, Tournier C. Physiological roles of MKK4 and MKK7: insights from animal models. Biochim Biophys Acta 2007;1773:1349-57.   DOI
11 Kang HS, Park MJ, Jin KS, Kim YH, Jun M, Lim HJ, Jo WK, Kim JS, Jeong WS. Regulatory roles of Chrysanthemum zawadskii roots in nuclear factor E2-related factor 2/antioxidant response element pathway. Food Sci Biotechnol 2008;17:367-72.
12 Zhang Y, Song M, Rui X, Pu S, Li Y, Li C. Supplemental dietary phytosterin protects against 4-nitrophenol-induced oxidative stress and apoptosis in rat testes. Toxicol Rep 2015;2:664-76.   DOI
13 Vivancos M, Moreno JJ. ${\beta}$-Sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages. Free Radical Biol Med 2005;39:91-7.   DOI
14 Beveridge THJ, Li TSC, Drover JCG. Phytosterol content in American ginseng seed oil. J Agric Food Chem 2002;50:744-50.   DOI
15 Nair S, Li W, Kong ANT. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacol Sin 2007;28:459-72.   DOI
16 Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008;60:79-127.   DOI
17 Bak MJ, Ok S, Jun M, Jeong WS. 6-Shogaol-rich extract from ginger up-regulates the antioxidant defense systems in cells and mice. Molecules 2012;17:8037-55.   DOI
18 Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong ANT. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 2006;66:11580-4.   DOI
19 Jeong WS, Jun M, Kong ANT. Nrf2: A potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006;8:99-106.   DOI
20 Kong ANT, Owuor E, Yu R, Hebbar V, Chen C, Hu R, Mandlekar S. Induction of xenobiotic enzymes by the map kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 2001;33:255-71.   DOI
21 Jeong GS, Lee DS, Li B, Byun E, Kwon DY, Park H, Kim YC. Protective effect of sauchinone by upregulating heme oxygenase-1 via the p38 MAPK and Nrf2/ARE pathways in HepG2 cells. Planta Med 2010;76:41-7.   DOI
22 Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 2005;331:993-1000.   DOI
23 Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010;50:323-54.   DOI
24 Lim JH, Kim KM, Kim SW, Hwang O, Choi HJ. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharm Res 2008;57:325-31.   DOI
25 Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, Ross D. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:1238-47.   DOI
26 Keum YS, Yu S, Chang PPJ, Yuan X, Kim JH, Xu C, Han J, Agarwal A, Kong ANT. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 Cells. Cancer Res 2006;66:8804-13.   DOI
27 Tanigawa S, Fujii M, Hou DX. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radical Biol Med 2007;42:1690-703.   DOI
28 Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006;78:2889-97.   DOI
29 Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997;236:313-22.   DOI
30 Lee JH, Khor TO, Shu L, Su Z-Y, Fuentes F, Kong ANT. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol Ther 2013;137:153-71.   DOI
31 Pearson G, Robinson F, Gibson TB, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-83.
32 Ryu JK, Lee T, Kim DJ, Park IS, Yoon SM, Lee HS, Song SU, Suh JK. Free radical-scavenging activity of Korean red ginseng for erectile dysfunction in non-insulin-dependent diabetes mellitus rats. Urology 2005;65:611-5.   DOI
33 Lee SD, Park SK, Lee ES, Kim HM, Lee CW, Lee K, Lee KH, Kang MR, Lee KS, Lee J, et al. A lipid-soluble red ginseng extract inhibits the growth of human lung tumor xenografts in nude mice. J Med Food 2010;13:1-5.   DOI
34 Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008;18:46-56.   DOI
35 Hwang JT, Lee MS, Kim HJ, Sung MJ, Kim HY, Kim MS, Kwon DY. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-[gamma] signal pathways. Phytother Res 2009;23:262-6.   DOI
36 Haniadka R, Popouri S, Palatty PL, Arora R, Baliga MS. Medicinal plants as antiemetics in the treatment of cancer: A review. Integr Cancer Ther 2012;11:18-28.   DOI
37 Park HJ, Lee JH, Song YB, Park KH. Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol Pharm Bull 1996;19:1434-9.   DOI
38 Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact 2012;195:154-64.   DOI
39 Morimitsu Y, Nakagawa Y, Hayashi K, Fujii H, Kumagai T, Nakamura Y, Osawa T, Horio F, Itoh K, Iida K, et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem 2002;277:3456-63.   DOI
40 Keum YS, Owuor ED, Kim BR, Hu R, Kong ANT. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm Res 2003;20:1351-6.   DOI
41 Andreadi CK, Howells LM, Atherfold PA, Manson MM. Involvement of Nrf2, p38, B-Raf, and nuclear factor-${\kappa}B$, but not phosphatidylinositol 3-kinase, in induction of Hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol 2006;69:1033-40.
42 Halimi M, Vahedi H, Lari J, Nasrabadi M. Chemical composition of n-hexane extratcs of the fruit from Bereberinse integrrima of Iran. Der Pharmacia Sin 2011;2:27-30.
43 Bak MJ, Hong SG, Lee JW, Jeong WS. Red ginseng marc oil inhibits iNOS and COX-2 via $NF{\kappa}B$ and p38 pathways in LPS-stimulated RAW 264.7 macrophages. Molecules 2012;17:13769-86.   DOI
44 Bak MJ, Jun M, Jeong WS. Antioxidant and hepatoprotective effects of the red ginseng essential oil in $H_2O_2$-treated HepG2 cells and $CCl_4$-treated mice. Int J Mol Sci 2012;13:2314-30.   DOI
45 Bak MJ, Kim KB, Jun M, Jeong WS. Safety of red ginseng oil for single oral administration in Sprague-Dawley rats. J Ginseng Res 2014;38:78-81.   DOI
46 Jeong WS, Keum YS, Chen C, Jain MR, Shen G, Kim JH, Li W, Kong ANT. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. Int J Biochem Mol Biol 2005;38:167-76.
47 Lee MH, Kim SS, Cho CW, Choi SY, In G, Kim KT. Quality and characteristics of ginseng seed oil treated using different extraction methods. J Ginseng Res 2013;37:468-74.   DOI
48 Liu YF, Yang XW,Wu B. GC-MS analysis of essential oil constituents from buds of Tussilago farfara L. J Chinese Pharm Sci 2006;15:10-4.
49 Grant DM. Detoxification pathways in the liver. J Inherit Metab Dis 1991;14:421-30.   DOI
50 Wilkening S, Stahl F, Bader A. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab Dispos 2003;31:1035-42.   DOI
51 Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 2000;12:5-11.   DOI
52 Hayes JD, McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 2001;174:103-13.   DOI
53 Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-80.   DOI
54 Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett 2004;215:129-40.   DOI
55 Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 2004;54:150-80.   DOI